Vormola R - Search Results

1

TEAM Study: Upfront Docetaxel Treatment in Patients With Metastatic Hormone-Sensitive Prostate Cancer: A Real-World, Multicenter, Retrospective Analysis.

Pisano C, Turco F, Arnaudo E, Fea E, Vanella P, Ruatta F, Filippi R, Brusa F, Prati V, Vana F, Mennitto A, Cattrini C, Vignani F, Dionisio R, Icardi M, Guglielmini P, Buosi R, Stevani I, Vormola R, Numico G, Depetris I, Comandone A, Gennari A, Airoldi M, Rossi M, Vellani G, Ortega C, Tucci M, Maio MD, Buttigliero C. Pisano C, et al. Among authors: vormola r. Clin Genitourin Cancer. 2024 Apr;22(2):56-67.e16. doi: 10.1016/j.clgc.2023.08.006. Epub 2023 Sep 7. Clin Genitourin Cancer. 2024. PMID: 37798164

2

Osteonecrosis of the jaw in prostate cancer patients with bone metastases treated with zoledronate: a retrospective analysis.

Ortega C, Montemurro F, Faggiuolo R, Vormola R, Nanni D, Goia F, Gilardino MO, Aglietta M. Ortega C, et al. Among authors: vormola r. Acta Oncol. 2007;46(5):664-8. doi: 10.1080/02841860601185917. Acta Oncol. 2007. PMID: 17562443

3

Comparison of endorectal magnetic resonance imaging, clinical prognostic factors and nomograms in the local staging of prostate cancer patients treated with radiotherapy.

Cirillo S, Petracchini M, Bona CM, Durando S, Ortega C, Vormola R, Stasi M, Malinverni G, Aglietta M, Regge D, Gabriele P. Cirillo S, et al. Among authors: vormola r. Tumori. 2008 Jan-Feb;94(1):65-9. doi: 10.1177/030089160809400112. Tumori. 2008. PMID: 18468337

4

Impact of concurrent radiotherapy on chemotherapy total dose and dose intensity in patients with early breast cancer.

Marenghi C, Guglielmini P, Verri E, Parodi M, Puntoni M, Usset A, Massoni C, Vormola R, Boccardo F. Marenghi C, et al. Among authors: vormola r. Tumori. 2005 Mar-Apr;91(2):126-30. doi: 10.1177/030089160509100204. Tumori. 2005. PMID: 15948538

5

Jaw complications in breast and prostate cancer patients treated with zoledronic acid.

Ortega C, Faggiuolo R, Vormola R, Montemurro F, Nanni D, Goia F, Aglietta M. Ortega C, et al. Among authors: vormola r. Acta Oncol. 2006;45(2):216-7. doi: 10.1080/02841860500341173. Acta Oncol. 2006. PMID: 16546871 No abstract available.

6

Prognostic factors in patients with metastatic germ cell tumors who experienced treatment failure with cisplatin-based first-line chemotherapy.

International Prognostic Factors Study Group; Lorch A, Beyer J, Bascoul-Mollevi C, Kramar A, Einhorn LH, Necchi A, Massard C, De Giorgi U, Fléchon A, Margolin KA, Lotz JP, Germa Lluch JR, Powles T, Kollmannsberger CK. International Prognostic Factors Study Group, et al. J Clin Oncol. 2010 Nov 20;28(33):4906-11. doi: 10.1200/JCO.2009.26.8128. Epub 2010 Oct 18. J Clin Oncol. 2010. PMID: 20956623

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

6 results

Search Page